---
title: "Full IDE dataset from AMDS PRESERVE trial presented at STS 2025"
date: "2025-01-27T16:31:56.000Z"
publishedDate: "27 janvier 2025"
summary: "Artivion has announced data from the AMDS PERSEVERE clinical trial presented in a late-breaking science presentation at the Society of Thoracic Surgeons (STS) 2025 annual meeting (25–27 January, Los Angeles, USA). The data include clinical outcomes across the full 93 study participant investigational device exemption (IDE) cohort at one year following AMDS implantation."
importance: ""
sourceUrl: "https://vascularnews.com/full-ide-dataset-from-amds-preserve-trial-presented-at-sts-2025/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-01-27-full-ide-dataset-from-amds-preserve-trial-presented-at-sts-2025"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2023/10/Artivion-logo-featured.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/full-ide-dataset-from-amds-preserve-trial-presented-at-sts-2025/"
---

![Full IDE dataset from AMDS PRESERVE trial presented at STS 2025](https://vascularnews.com/wp-content/uploads/sites/7/2023/10/Artivion-logo-featured.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/full-ide-dataset-from-amds-preserve-trial-presented-at-sts-2025/*

## L’essentiel

Artivion has announced data from the AMDS PERSEVERE clinical trial presented in a late-breaking science presentation at the Society of Thoracic Surgeons (STS) 2025 annual meeting (25–27 January, Los Angeles, USA). The data include clinical outcomes across the full 93 study participant investigational device exemption (IDE) cohort at one year following AMDS implantation.

## Lien source

https://vascularnews.com/full-ide-dataset-from-amds-preserve-trial-presented-at-sts-2025/
